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There is a natural decline in cognitive function as we age,
particularly in processing speed and working memory. A
range ofmodifiable factors can increase the risk of accelerated
cognitive decline including hypertension, chronic inflamma-
tion, atherosclerosis, diabetes, atrial fibrillation, stroke, and
impaired central nervous system glucose regulation. Given
the lack of adequate interventions for cognitive decline and
dementia, it is essential that treatments with the potential
to reduce the risk of cognitive impairment are thoroughly
explored.
Nutraceutical and lifestylemedicines, including vitamins,
herbs, supplements, physical activity, and diet, have been
shown to possess anti-inflammatory, antihyperglycaemic,
and antihypertensive properties, suggesting their utility in
targeting the pathophysiology associated with risk for cog-
nitive decline. The purpose of this special issue was to
explore the role of such complementary medicines in the
modification of risk factors for cognitive decline.
Authors contributed with a range of papers including
original research and review articles spanning in vitro, in
vivo, and human studies that improve the understanding
of the pathology involved in cognitive impairment in older
age and the development of evidence-based complementary
treatment strategies for cognitive decline. This collection of
works provides a snapshot (that is by no means exhaustive)
of current research and some of the emerging trends in this
field. This special issue features 11 papers including 4 reviews
and 7 original research articles.The complementary therapies
explored include nutritional supplements (2 papers), herbal
and traditional medicines (6 papers), physical activity (1
paper), and electroacupuncture (2 papers). A brief descrip-
tion of these 11 works is detailed below.
(i) Clinical trials involving nutraceutical and herbal
medicine interventions for people with mild cog-
nitive impairment and dementia are reviewed in
G. Z. Steiner et al. The manuscript titled “A Sys-
tematic Review of Intervention Studies Examining
Nutritional and Herbal Therapies for Mild Cogni-
tive Impairment and Dementia Using Neuroimaging
Methods: Study Characteristics and Intervention Effi-
cacy” focuses on papers that feature neuroimaging
outcome measures.
(ii) D. Chang et al. provide a detailed review of the
literature on herbalmedicine for vascular dementia in
their paper titled “Herbal Medicine for the Treatment
of Vascular Dementia: An Overview of Scientific
Evidence.”
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(iii) Vascular disease, such as cerebrovascular disease and
atherosclerosis are risk factors for cognitive impair-
ment. X. Zhou et al. review the evidence on this link
and promising Traditional ChineseMedicines in their
paper titled “Vascular Contributions to Cognitive
Impairment andTreatments with Traditional Chinese
Medicine.”
(iv) The fourth review featured in this special issue
summarises the evidence on the efficacy of physical
activity in reducing depression. D. C. Mathersul and
S. Rosenbaum’s paper is titled “The Roles of Exercise
and Yoga in Ameliorating Depression as a Risk Factor
for Cognitive Decline.”
(v) H. Macpherson et al. outline the findings of a clin-
ical trial on older adults in their paper titled “The
Effects of Four-Week Multivitamin Supplementation
on Mood in Healthy Older Women: A Randomized
Controlled Trial.”
(vi) Thefirst preclinical paper in this special issue explores
the effectiveness of Huannao Yicong extract, a Tradi-
tional Chinese Medicine, in reducing tau hyperphos-
phorylation in Alzheimer’s disease model rats. Y. Cao
et al.’s paper is titled “Traditional Chinese Medicine
Huannao Yicong Decoction Extract Decreases Tau
Hyperphosphorylation in the Brain of Alzheimer’s
Disease Model Rats Induced by A𝛽
1–42.”
(vii) X. Wang et al. report their findings from an elec-
troacupuncture treatment on Alzheimer’s disease
model mice in their paper titled “Improvement of
Electroacupuncture on APP/PS1 Transgenic Mice
in Spatial Learning and Memory probably due to
Expression of A𝛽 and LRP1 in Hippocampus.”
(viii) The second electroacupuncture paper in this special
issue explores the effects of this treatment on cerebral
hypoperfusion model rats. C.-X. Zheng et al.’s paper
is titled “Electroacupuncture Ameliorates Learning
and Memory and Improves Synaptic Plasticity via
Activation of the PKA/CREB Signaling Pathway in
Cerebral Hypoperfusion.”
(ix) In the paper titled “Preservation of Cognitive Func-
tion by Lepidium meyenii (Maca) Is Associated with
Improvement of Mitochondrial Activity and Upreg-
ulation of Autophagy-Related Proteins in Middle-
Aged Mouse Cortex” by S.-S. Guo et al., maca (a
traditional Andean medicine) was found to improve
cognition and behavior, and mitochondrial dysfunc-
tion in middle-aged mice.
(x) In an in vitro study by L. Liu et al., the effects
of A𝛽-induced neurotoxicity on SH-SY5Y cells are
modulated by a the Traditional ChineseMedicine, Yi-
Zhi-Fang-Dai formula. The paper is titled “Yi-Zhi-
Fang-Dai Formula Protects against A𝛽
1–42 Oligomer
Induced Cell Damage via Increasing Hsp70 and
Grp78 Expression in SH-SY5Y Cells.”
(xi) The final paper in this special issue by M. A. Akhtar
et a. titled “Medicinal Plants of the Australian Aborig-
inal Dharawal People Exhibiting Anti-Inflammatory
Activity” explores the medicinal effects of a range
of Eucalyptus plants used in traditional Australian
Aboriginal medicine by the Dharawal people.
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